My HPRA: Register

The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Ozalin 2 mg/ml oral solution in single-dose container



Primex Pharmaceuticals OyPA1719/002/001

Main Information

Trade NameOzalin 2 mg/ml oral solution in single-dose container
Active SubstancesMidazolam
Dosage FormOral solution in single-dose container
Licence HolderPrimex Pharmaceuticals Oy
Licence NumberPA1719/002/001

Group Information

ATC CodeN05CD08 midazolam

Status

License statusAuthorised
Licence Issued23/04/2020
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceThis product contains a substance listed in schedule 4, part 1 to the Misuse of Drugs Regulations 2017.
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back
Follow medicine

Print